interferon

(redirected from Interferon beta-1a)
Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to Interferon beta-1a: Interferon beta-1b, Rebif, Glatiramer acetate, Avonex

in·ter·fer·on

 (ĭn′tər-fîr′ŏn′)
n.
1. Any of a group of glycoproteins that are produced by different cell types in response to various stimuli, such as exposure to a virus, bacterium, parasite, or other antigen, and that inhibit infection through mechanisms such as preventing viral replication or regulating the immune system.
2. Any of a group of synthetic glycoproteins that are structurally similar to these compounds and are used therapeutically, especially as antivirals.

interferon

(ˌɪntəˈfɪərɒn)
n
(Biochemistry) biochem any of a family of proteins made by cells in response to virus infection that prevent the growth of the virus. Some interferons can prevent cell growth and have been tested for use in cancer therapy
[C20: from interfere + -on]

in•ter•fer•on

(ˌɪn tərˈfɪər ɒn)

n.
any of various proteins, produced by virus-infected cells, that inhibit reproduction of the invading virus and induce resistance to further infection.
[1957; interfere + -on1]

in·ter·fer·on

(ĭn′tər-fîr′ŏn′)
Any of a group of proteins that are produced by animal cells in response to infection by a virus and that, in many cases, prevent replication of the virus. Some interferons trigger an immune response in the body. They have been investigated as treatment for many diseases, including certain cancers.

interferon

Immune system proteins that help to protect cells against attack by some kinds of viruses.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.interferon - an antiviral protein produced by cells that have been invaded by a virus; inhibits replication of the virus
alpha-interferon - a form of interferon that is produced endogenously and commercially for its pharmacological effects (including regulation of the immune system and antiviral and antineoplastic effects)
antiviral, antiviral agent, antiviral drug - any drug that destroys viruses
beta-interferon - a form of interferon that is produced by fibroblasts and have antiviral effects; used in the treatment of multiple sclerosis
gamma-interferon - a form of interferon that is produced by T cells and macrophages; involved in the activation of phagocytes
Translations

interferon

[ˌɪntəˈfɪərɒn] Ninterferón m

interferon

n (Chem) → Interferon nt

in·ter·fer·on

n. interferón, proteína natural liberada por células expuestas a la acción del virus que se usa en el tratamiento de infecciones y neoplasmas.

interferon

n interferón m; alpha (beta, etc.) interferon interferón alfa (beta, etc.); pegylated — interferón pegilado
References in periodicals archive ?
The study, which was carried out at 87 sites in 25 countries, investigated the safety and efficacy of the product compared with interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis.
S/P por exclusividad 22/2017 HUP, medicamentos: Fampridina, Interferon Beta-1A y Natalizumab.
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis.
The package insert included in the original Food and Drug Administration application for intramuscular interferon beta-1a (Avonex) stated that some patients in the treatment group reported decreased hearing sensitivity.
The drug significantly lowers the number of attacks (or relapses) experienced by people with MS compared to those patients who are treated with current drug, interferon beta-1a.
SAN DIEGO--Glatiramer acetate and interferon beta-1a used in combination were no more effective for patients with relapsing-remitting multiple sclerosis than were either agent alone in a 3-year, randomized trial.
On quality of life measures, monotherapy and combination therapy proved largely equal--and equally well tolerated--in the "'CombiRx" study, in which half of the patients got the combination and a quarter got either glatiramer acetate (Copaxone) or interferon beta-1a (Avonex) alone plus a placebo.
of Haukeland University Hospital, Bergen, Norway, and colleagues included 92 patients with multiple sclerosis in their double-blind, placebo-controlled trial to examine whether omega-3 fatty acid supplementation as a monotherapy (single therapy) or in combination with subcutaneous (under the skin) interferon beta-1a could reduce disease activity.
Researchers compared the effectiveness of alemtuzumab with interferon beta-1a, a leading MS treatment.
Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis.
Se trata del interferon beta-1a y el natalizumab, cuyo uso simultaneo hace mas lento el avance de la atrofia cerebral, en especial ta destruccion de la materia gris.

Full browser ?